Back Back to portfolio

Pentabind

Pentabind is a drug development company that uses artificial intelligence to design aptamer-based drugs

www.pentabind.com

 

Founded In

2022

Fund

Hoxton IV

Headquarters

London

Invested In

2025

Hoxton Partners

Hussein Kanji